Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer

NCT04546373 · clinicaltrials.gov ↗

COMPLETED

Status

316

Enrollment

OTHER

Sponsor class

Conditions

Epithelial Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer

Interventions

DRUG: Niraparib

Sponsor

Grupo Español de Investigación en Cáncer de Ovario